Literature DB >> 225354

Metabolic fate of chylomicron phospholipids and apoproteins in the rat.

A R Tall, P H Green, R M Glickman, J W Riley.   

Abstract

To study the metabolic fate of chylomicron phospholipid and apoproteins, 15 mg of doubly labeled ([(3)H]leu, [(32)P]phospholipid) rat mesenteric lymph chylomicrons were injected as an intravenous bolus into conscious rats. The specific radioactivity, composition, pool size, and morphology of the plasma lipoproteins were determined after 2-60 min. After injection of chylomicrons, there was a rapid transfer of radioactivity into high density lipoproteins (HDL). At peak specific activity in HDL (2-5 min), 35% of injected apoprotein and 25% of phospholipid radioactivity were recovered in HDL (d 1.063-1.21 g/ml), with smaller recoveries in other lipoproteins and liver. There was an initial rapid rise of (32)P specific activity in HDL and d 1.02-1.063 lipoproteins (low density lipoproteins [LDL]), but whereas LDL specific activity subsequently converged with that of d < 1.02 lipoproteins, HDL specific activity decayed more rapidly than LDL or d < 1.02 lipoproteins. Lipolysis of chylomicrons was associated with a transfer of phospholipid mass into LDL and HDL. At 5 min, 80% of injected triglyceride had been lipolyzed and there was a significant increase in phospholipid mass in LDL and a smaller increase in HDL. At 10 min, the mass of phospholipid in LDL had returned towards control values, and there was a further increase in phospholipid mass in HDL, which suggested phospholipid transfer from LDL to HDL. In donor lymph chylomicrons (3)H-radioactivity was present in apoprotein (apo)B, apoA-I, and apoA-IV, but only radioactivity of apoA-I and apoA-IV were transferred to HDL. Transfer of radioactivity was associated with loss of mass of apoA-I and apoA-IV from the fraction that contained the chylomicron remnants (d < 1.02). With injection of 15 mg chylomicron, there was a small but insignificant increase in the relatively large pool of HDL apoA-I. However, 60 min after injection of 250 mg of human or rat intestinal chylomicrons into the rat, there was a significant increase in HDL apoA-I that resulted from acquisition of a major fraction of the chylomicron apoA-I. After injection of chylomicrons, phospholipid vesicles were observed by negative stain electron microscopy in the LDL and HDL ultracentrifugal fractions, especially in the LDL. Upon addition of an osmotically active compound, cellobiose, vesicles were observed as flattened particles with a double lipid bilayer thickness ( congruent with 100 A). To validate further the identity of these particles, chylomicrons were injected into rats with [(3)H]glucose, and the recipient rats' plasma was fractionated by chromatography on 6% agarose. Trapping of [(3)H]glucose occurred in the void and LDL regions of the column, and vesicular particles were identified in these column fractions by negative stain electron microscopy. Catabolism of chylomicrons is associated with a rapid transfer of phospholipid, apoA-I, and possibly apoA-IV into HDL. Chylomicron phospholipid appears to give rise to vesicles which are probably incorporated into preexisting HDL. Chylomicron surface components may be an important source of plasma HDL.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225354      PMCID: PMC372206          DOI: 10.1172/JCI109564

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  METABOLISM OF CONSTITUENT LIPIDS OF DOG CHYLOMICRONS.

Authors:  P J NESTEL; R J HAVEL; A BEZMAN
Journal:  J Clin Invest       Date:  1963-08       Impact factor: 14.808

2.  Early effects of fat ingestion on lipids and lipoproteins of serum in man.

Authors:  R J HAVEL
Journal:  J Clin Invest       Date:  1957-06       Impact factor: 14.808

Review 3.  Lipoprotein apoprotein metabolism.

Authors:  E J Schaefer; S Eisenberg; R I Levy
Journal:  J Lipid Res       Date:  1978-08       Impact factor: 5.922

4.  SITES OF INITIAL REMOVAL OF CHYLOMICRON TRIGLYCERIDE FATTY ACIDS FROM THE BLOOD.

Authors:  P J Nestel; R J Havel; A Bezman
Journal:  J Clin Invest       Date:  1962-10       Impact factor: 14.808

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions.

Authors:  D P BARR; E M RUSS; H A EDER
Journal:  Am J Med       Date:  1951-10       Impact factor: 4.965

7.  Solubilisation of phospholipid membranes by human plasma high density lipoproteins.

Authors:  A R Tall; D M Small
Journal:  Nature       Date:  1977-01-13       Impact factor: 49.962

8.  Interaction of plasma high density lipoproteins with dimyristoyllecithin multilamellar liposomes.

Authors:  A R Tall; V Hogan; L Askinazi; D M Small
Journal:  Biochemistry       Date:  1978-01-24       Impact factor: 3.162

9.  Selective deficiency of hepatic triglyceride lipase in uremic patients.

Authors:  R Mordasini; F Frey; W Flury; G Klose; H Greten
Journal:  N Engl J Med       Date:  1977-12-22       Impact factor: 91.245

10.  Abnormal plasma lipoproteins and lecithin-cholesterol acyltransferase deficiency in alcoholic liver disease.

Authors:  S M Sabesin; H L Hawkins; L Kuiken; J B Ragland
Journal:  Gastroenterology       Date:  1977-03       Impact factor: 22.682

View more
  35 in total

Review 1.  Optimized negative-staining electron microscopy for lipoprotein studies.

Authors:  Lei Zhang; Huimin Tong; Mark Garewal; Gang Ren
Journal:  Biochim Biophys Acta       Date:  2012-09-29

2.  [Phospholipids as emulsifiers in fat emulsions--effect on phospholipids in the serum lipoprotein fraction d greater than 1.063].

Authors:  S Hailer; S Kalb; G Wolfram
Journal:  Z Ernahrungswiss       Date:  1988-03

3.  Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver.

Authors:  E M Quinet; L B Agellon; P A Kroon; Y L Marcel; Y C Lee; M E Whitlock; A R Tall
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

4.  Lipoprotein receptor mediated metabolism of [14C]arachidonic acid labeled chylomicron remnants by Hep G2 cells.

Authors:  Q Chen; C H Florén; A Nilsson
Journal:  Lipids       Date:  1992-09       Impact factor: 1.880

5.  The apoprotein B-independent hepatic uptake of chylomicron remnants.

Authors:  J Borensztajn; G S Getz; R J Padley; T J Kotlar
Journal:  Biochem J       Date:  1982-05-15       Impact factor: 3.857

6.  Apoprotein-independent binding of chylomicron remnants to rat liver membranes.

Authors:  J Borensztajn; T J Kotlar; S Y Chang
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

7.  Human apolipoprotein A-IV. Intestinal origin and distribution in plasma.

Authors:  P H Green; R M Glickman; J W Riley; E Quinet
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

8.  Deficiency in lysophosphatidylcholine acyltransferase 3 reduces plasma levels of lipids by reducing lipid absorption in mice.

Authors:  Zhiqiang Li; Hui Jiang; Tingbo Ding; Caixia Lou; Hai H Bui; Ming-Shang Kuo; Xian-Cheng Jiang
Journal:  Gastroenterology       Date:  2015-07-27       Impact factor: 22.682

9.  Effects of Triton WR 1339 and heparin on the transfer of surface lipids from triglyceride-rich emulsions to high density lipoproteins in rats.

Authors:  R C Maranhão; I A Roland; M H Hirata
Journal:  Lipids       Date:  1990-11       Impact factor: 1.880

10.  The effect of insulin deficiency on the plasma clearance and exchange of high-density-lipoprotein phosphatidylcholine in rats.

Authors:  I J Martins; T G Redgrave
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.